I break down what is really happening inside Palantir and why this stock has become one of the most controversial AI plays heading into 2026. I walk through the latest government deals, explosive financial growth, and why expectations are now higher than ever. This video lays out the full bull, base
1 extracted signal · 1 resolved · 0 still active
Rick Orford - Trading Stocks and Options For AllIndependent analyst profile- Source published
- 30 Dec 2025, 21:00 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
Palantir Technologies (PLTR) is demonstrating strong growth, with revenue up 63% year-over-year and gross margins at 82%. The company has secured significant government contracts, including a three-year renewal with France's DGSI and a multi-year deal with PwC UK to expand AI adoption. Despite high valuations, the stock is still considered a buy by analysts, with a consensus average rating of 'Hold' and a target price of $255, suggesting potential upside. However, risks include government budget constraints and competitive pressures that could impact future revenue.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Rick Orford - Trading Stocks and Options For All
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
